These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 26826307

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P, Lutsiak CM, Hamdy S, Diwan M, Samuel J.
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination.
    Mittal A, Schulze K, Ebensen T, Weissmann S, Hansen S, Guzmán CA, Lehr CM.
    J Control Release; 2015 May 28; 206():140-52. PubMed ID: 25795506
    [Abstract] [Full Text] [Related]

  • 25. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X, Duan J, Li X, Zhu X, Chen Y, Wang X, Sun H, Kong D, Li C, Yang J.
    Nanoscale; 2018 May 24; 10(20):9489-9503. PubMed ID: 29675543
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
    Ma W, Chen M, Kaushal S, McElroy M, Zhang Y, Ozkan C, Bouvet M, Kruse C, Grotjahn D, Ichim T, Minev B.
    Int J Nanomedicine; 2012 May 24; 7():1475-87. PubMed ID: 22619507
    [Abstract] [Full Text] [Related]

  • 28. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q, Tan MT, Keegan BP, Barry MA, Heffernan MJ.
    Biomaterials; 2014 Sep 24; 35(29):8385-93. PubMed ID: 24986256
    [Abstract] [Full Text] [Related]

  • 29. The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant.
    Zhang Y, Gu P, Wusiman A, Xu S, Ni H, Qiu T, Liu Z, Hu Y, Liu J, Wang D.
    Int J Nanomedicine; 2020 Sep 24; 15():5527-5543. PubMed ID: 32848386
    [Abstract] [Full Text] [Related]

  • 30. PLGA nanoparticles enhance the expression of retinaldehyde dehydrogenase enzymes in dendritic cells and induce FoxP3(+) T-cells in vitro.
    Keijzer C, Spiering R, Silva AL, van Eden W, Jiskoot W, Vervelde L, Broere F.
    J Control Release; 2013 May 28; 168(1):35-40. PubMed ID: 23500056
    [Abstract] [Full Text] [Related]

  • 31. Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines.
    Xu P, Tang S, Jiang L, Yang L, Zhang D, Feng S, Zhao T, Dong Y, He W, Wang R, Zhang J, Liang Z.
    J Control Release; 2016 Mar 10; 225():252-68. PubMed ID: 26826303
    [Abstract] [Full Text] [Related]

  • 32. Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen.
    De Temmerman ML, Rejman J, Vandenbroucke RE, De Koker S, Libert C, Grooten J, Demeester J, Gander B, De Smedt SC.
    J Control Release; 2012 Mar 10; 158(2):233-9. PubMed ID: 22063002
    [Abstract] [Full Text] [Related]

  • 33. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
    Kang S, Ahn S, Lee J, Kim JY, Choi M, Gujrati V, Kim H, Kim J, Shin EC, Jon S.
    J Control Release; 2017 Jun 28; 256():56-67. PubMed ID: 28428066
    [Abstract] [Full Text] [Related]

  • 34. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response.
    Fischer S, Schlosser E, Mueller M, Csaba N, Merkle HP, Groettrup M, Gander B.
    J Drug Target; 2009 Sep 28; 17(8):652-61. PubMed ID: 19622019
    [Abstract] [Full Text] [Related]

  • 35. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.
    Khademi F, Sahebkar A, Fasihi-Ramandi M, Taheri RA.
    APMIS; 2018 Jun 28; 126(6):509-514. PubMed ID: 29924445
    [Abstract] [Full Text] [Related]

  • 36. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
    Varypataki EM, Silva AL, Barnier-Quer C, Collin N, Ossendorp F, Jiskoot W.
    J Control Release; 2016 Mar 28; 226():98-106. PubMed ID: 26876760
    [Abstract] [Full Text] [Related]

  • 37. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M, Lin MY, Bal SM, van Meijgaarden KE, Franken KL, Friggen AH, Junginger HE, Borchard G, Klein MR, Ottenhoff TH.
    Vaccine; 2009 Jun 19; 27(30):4010-7. PubMed ID: 19389445
    [Abstract] [Full Text] [Related]

  • 38. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
    Silva AL, Rosalia RA, Varypataki E, Sibuea S, Ossendorp F, Jiskoot W.
    Vaccine; 2015 Feb 11; 33(7):847-54. PubMed ID: 25576216
    [Abstract] [Full Text] [Related]

  • 39. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses.
    Liu J, Liu X, Han Y, Zhang J, Liu D, Ma G, Li C, Liu L, Kong D.
    ACS Appl Mater Interfaces; 2018 Sep 19; 10(37):30983-30993. PubMed ID: 30136844
    [Abstract] [Full Text] [Related]

  • 40. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
    Mittal A, Raber AS, Schaefer UF, Weissmann S, Ebensen T, Schulze K, Guzmán CA, Lehr CM, Hansen S.
    Vaccine; 2013 Jul 25; 31(34):3442-51. PubMed ID: 23290836
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.